Peptides take center stage on Hims House podcast
APC CEO Scott Brunner joins the Hims House podcast to discuss peptides, FDA uncertainty, APC’s proposed guardrails, and two meetings with the agency.
Being an exceptional compounding professional means you never stop learning
We advocate for compounding pharmacies and facilities on a range of state and federal issues affecting patient access to compounded medications. We represent pharmacists and technicians in both traditional 503A compounding pharmacies and 503B outsourcing facilities, as well as prescribers, patients, educators, and suppliers. We’re 5,000 members strong and growing.
APC CEO Scott Brunner joins the Hims House podcast to discuss peptides, FDA uncertainty, APC’s proposed guardrails, and two meetings with the agency.
A new entry on the federal government’s regulatory review website indicates that FDA has submitted an action titled “Interim Access Policy for ...
This year's series covered hormone compounding from every angle. Topics include perimenopause care for a younger, often overlooked patient ...
Start with credit card processing. APC's partnership with The Processing Brokerage gives PFMs access to Tabz or WorldPay, and the 60-Second Audit at ...
Today is the last day for APC members to stack an exclusive discount on registration for the Compounding Pharmacy Compliance Year-End Update, ...
Unapproved obesity drug spawns a black market frenzy